查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697434

OTC益生菌補充劑市場：未來預測（2025-2030）

OTC Probiotics Supplement Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2025 年，非處方益生菌補充劑市場價值將達到 169.53 億美元，複合年成長率為 9.78%，到 2030 年市場規模將達到 270.29 億美元。

非處方益生菌補充劑市場受到人們日益增強的健康意識的推動，從而導致益生菌補充劑的流行。此外，益生菌應用範圍的不斷擴大預計將在未來幾年推動需求的成長。此外，在美國、德國等已開發國家，人們對免疫力和心理健康的興趣日益濃厚，對醫療營養的前景看好，推動了市場擴張。此外，非處方益生菌的可用性和便利性正在推動市場成長。

市場趨勢：

  • 擴大應用為製造商和供應商創造了成長機會：隨著研發力度的加大，益生菌的潛在應用預計在預測期內將擴大。成藥益生菌取代其他藥物的日子可能即將到來。隨著消費者對益生菌健康益處的認知不斷提高，預計市場將呈指數級成長。此外，成藥益生菌的日益普及以及先進和新型口味益生菌產品的推出預計將進一步擴大製造商和供應商的成長機會。
  • 對創新和便利的益生菌形式的需求不斷成長：對軟糖、咀嚼片和粉末等便捷的益生菌輸送形式的偏好正在推動人們轉向更方便用戶使用的選擇。
  • 亞太地區的成長：受城市人口成長和可支配收入增加導致的需求增加的推動，亞太地區的非處方益生菌市場預計將快速成長。
  • 北美市場領導地位：受成熟市場和注重健康的消費者的推動，北美佔據非處方益生菌補充劑市場的大部分佔有率。該地區對非處方益生菌產品的購買趨勢也日益成長。

報告中介紹的主要企業包括杜邦、達能、Probi AB、Lifeway Foods, Inc.、Kibow Biotech、Pharmavite LLC、Osmotica Pharmaceuticals Corp、Dietary Pros, Inc. 和荷蘭皇家帝斯曼。

本報告的主要優點

  • 深刻分析：獲得涵蓋主要地區和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業採取的策略策略，並了解正確策略帶來的潛在市場滲透。
  • 市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
  • 適用範圍廣：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說，它都是實用且具有成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024）和預測資料（2025-2030）
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按部門和地區（國家）分類的收益成長和預測分析
  • 公司概況（策略、產品、財務資訊、主要趨勢等）

OTC益生菌補充劑市場細分為：

按形狀

  • 膠囊
  • 錠劑
  • 粉末/糖漿

按成分

  • Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Yeast

按健康類別

  • 腸道健康
  • 整體健康
  • 免疫力
  • 心理健康
  • 其他

按分銷管道

  • 線上
  • 離線

按地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

目錄

第1章 引言

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章分析方法

  • 分析設計
  • 分析過程

第3章執行摘要

  • 主要發現

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

5. 非處方益生菌補充劑市場（按形式）

  • 介紹
  • 膠囊
  • 錠劑
  • 粉末/糖漿

6. 非處方益生菌補充劑市場（依成分）

  • 介紹
  • 細菌
    • 乳酸菌
    • 雙歧桿菌
    • 嗜熱鏈球菌
  • 酵母菌

7. 非處方益生菌補充劑市場（依健康類別）

  • 介紹
  • 腸道健康
  • 一般健康
  • 免疫
  • 心理健康
  • 其他

8. 非處方益生菌補充劑市場（依分銷管道）

  • 介紹
  • 線上
  • 離線

9. 非處方益生菌補充劑市場（按地區）

  • 介紹
  • 北美洲
    • 按形狀
    • 按成分
    • 按健康類別
    • 按分銷管道
    • 按國家
  • 南美洲
    • 按形狀
    • 按成分
    • 按健康類別
    • 按分銷管道
    • 按國家
  • 歐洲
    • 按形狀
    • 按成分
    • 按健康類別
    • 按分銷管道
    • 按國家
  • 中東和非洲
    • 按形狀
    • 按成分
    • 按健康類別
    • 按分銷管道
    • 按國家
  • 亞太地區
    • 按形狀
    • 按成分
    • 按健康類別
    • 按分銷管道
    • 按國家

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 企業合併、協議、商業合作
  • 競爭儀錶板

第11章 公司簡介

  • DuPont
  • Danone
  • Probi AB
  • Lifeway Foods, Inc.
  • Kibow Biotech
  • Pharmavite LLC
  • Osmotica Pharmaceuticals Corp
  • Dietary Pros, Inc.
  • Royal DSM

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061613807

The OTC Probiotics Supplement Market, valued at US$16.953 billion in 2025, is projected to grow at a CAGR of 9.78%, reaching a market size of US$27.029 billion by 2030.

The market for OTC probiotics supplements is driven by rising health awareness among individuals, leading to the popularity of probiotic supplements. In addition, the expanding scope of probiotics application is anticipated to boost the demand in the coming years. Furthermore, there is a favorable outlook of people toward medical nutrition in developed countries like the United States and Germany, among others, due to an increased focus on immunity and mental health, which is driving market expansion. Moreover, OTC probiotics' easy availability and convenience are propelling the market growth.

Market Trends:

  • Expanding Applications Create Growth Opportunities for Manufacturers and Vendors: With increasing research and development efforts, the potential applications of probiotics are expected to broaden during the forecast period. OTC pharmaceutical probiotics may soon replace other pharmaceutical agents. The market is poised for exponential growth as consumer awareness of the health benefits of probiotics rises. Additionally, the introduction of advanced and new flavored probiotic products, along with the growing popularity of OTC pharmaceutical probiotics, is expected to further expand growth opportunities for manufacturers and vendors.
  • Rising Demand for Innovative and Convenient Probiotic Formats: There is a growing preference for convenient probiotic delivery formats such as gummies, chewables, and powders, driving a shift toward more user-friendly options.
  • Asia-Pacific Growth: The Asia-Pacific region is expected to experience rapid growth in the OTC probiotics market, fueled by increasing demand from the expanding urban population and rising disposable incomes.
  • North America's Market Leadership: North America holds a significant share of the OTC probiotics supplement market, supported by its established market and health-conscious consumers. The region is also witnessing a growing trend toward targeted OTC probiotic products.

Some of the major players covered in this report include DuPont, Danone, Probi AB, Lifeway Foods, Inc., Kibow Biotech, Pharmavite LLC, Osmotica Pharmaceuticals Corp, Dietary Pros, Inc., and Royal DSM, among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

OTC Probiotics Supplement Market is analyzed into the following segments:

By Form

  • Capsules
  • Tablets
  • Powder & Syrups

By Ingredients

  • Bacteria
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Yeast

By Health Area

  • Gut Health
  • General Health
  • Immunity
  • Mental Well-Being
  • Others

By Distribution Channel

  • Online
  • Offline

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. OTC PROBIOTICS SUPPLEMENT MARKET BY FORM

  • 5.1. Introduction
  • 5.2. Capsules
  • 5.3. Tablets
  • 5.4. Powder & Syrups

6. OTC PROBIOTICS SUPPLEMENT MARKET BY INGREDIENTS

  • 6.1. Introduction
  • 6.2. Bacteria
    • 6.2.1. Lactobacilli
    • 6.2.2. Bifidobacterium
    • 6.2.3. Streptococcus Thermophilus
  • 6.3. Yeast

7. OTC PROBIOTICS SUPPLEMENT MARKET BY HEALTH AREA

  • 7.1. Introduction
  • 7.2. Gut Health
  • 7.3. General Health
  • 7.4. Immunity
  • 7.5. Mental Well-Being
  • 7.6. Others

8. OTC PROBIOTICS SUPPLEMENT MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Online
  • 8.3. Offline

9. OTC PROBIOTICS SUPPLEMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Form
    • 9.2.2. By Ingredients
    • 9.2.3. By Health Area
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Form
    • 9.3.2. By Ingredients
    • 9.3.3. By Health Area
    • 9.3.4. By Distribution Channel
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Form
    • 9.4.2. By Ingredients
    • 9.4.3. By Health Area
    • 9.4.4. By Distribution Channel
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Form
    • 9.5.2. By Ingredients
    • 9.5.3. By Health Area
    • 9.5.4. By Distribution Channel
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Form
    • 9.6.2. By Ingredients
    • 9.6.3. By Health Area
    • 9.6.4. By Distribution Channel
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. DuPont
  • 11.2. Danone
  • 11.3. Probi AB
  • 11.4. Lifeway Foods, Inc.
  • 11.5. Kibow Biotech
  • 11.6. Pharmavite LLC
  • 11.7. Osmotica Pharmaceuticals Corp
  • 11.8. Dietary Pros, Inc.
  • 11.9. Royal DSM

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations